Pfizer Is Ordered to Pay $850,000 to Brigham Young U. for Delaying Patent Litigation

Brigham Young University, which is suing Pfizer Inc. for billions of dollars claiming the giant pharmaceutical company’s drug Celebrex infringes a university-owned patent, was awarded more than $850,000 from the company by a federal magistrate after she found that Pfizer had repeatedly delayed the progress of the case, The Salt Lake Tribune reported. The university has also claimed that Pfizer destroyed some evidence that would have shown that a BYU professor played a key role in developing the drug.